## SCHW: The Charles Schwab Corporation - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 2.6% below STRENGTH zone (3.0-6.0%); RSI 72 overbought. Stock is in no-man's land without clear edge. Caution: overbought RSI (72).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($100.14)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 5, Bearish: 0)

**1. Charles Schwab stock hits all-time high at 102.34 USD**
- Source: Investing.com | 20260105T150821 | Bullish | Relevance: 100%
- Charles Schwab (SCHW) stock has reached an all-time high of $102.34, now trading at $103.46, marking a 38.88% increase over the past year. The company's strong performance is supported by a market capitalization of $183.65 billion, 21.67% revenue growth, and 37 years of consistent dividend payments. Upcoming earnings on January 21st are expected to provide further insights into its financial strategies.

**2. Charles Schwab (SCHW): Valuation Check After Record Q3 2025 Results and Surging Institutional Demand**
- Source: Simply Wall Street | 20260105T000855 | Somewhat-Bullish | Relevance: 100%
- Charles Schwab (SCHW) has reported record third-quarter 2025 results, with its stock performing strongly and attracting significant institutional interest. Despite trading near all-time peaks and a modest discount to analyst targets, Simply Wall St assesses the company as 9.9% undervalued against a fair value of $112.79, driven by expected digital transformation and operational enhancements. However, the analysis acknowledges potential risks from increased competition and reduced net interest income.

**3. Charles Schwab stock rises to start 2026 as rate bets and key data loom**
- Source: ts2.tech | 20260103T215122 | Bullish | Relevance: 100%
- Charles Schwab (SCHW) stock rose 1.7% to $101.57 as 2026 began, driven by a broad Wall Street rebound and investor focus on upcoming interest rate data and the company's earnings. The brokerage's performance is closely tied to interest rates and client cash behavior, with key economic data and Schwab's Q4 2025 earnings report scheduled for later in January expected to influence its trajectory.

**4. Charles Schwab stock price target raised to $114 by Raymond James**
- Source: Investing.com India | 20260105T190549 | Bullish | Relevance: 100%
- Raymond James raised its price target on Charles Schwab Corp. (NYSE:SCHW) to $114 from $110, maintaining a Strong Buy rating due to the company's improving financial outlook and strong retail trading activity. Schwab is considered undervalued based on its Fair Value assessment and expects significant earnings per share growth in 2026. The firm anticipates the company will return substantial capital to shareholders in the coming quarters.

**5. Charles Schwab stock hits all-time high at 102.34 USD By Investing.com**
- Source: Investing.com South Africa | 20260105T150140 | Bullish | Relevance: 100%
- Charles Schwab Corp. has reached an all-time high stock price of $102.34, currently trading at $103.46, representing a 38.88% increase over the past year. This milestone, backed by a market capitalization of $183.65 billion and 21.67% revenue growth, reflects robust performance and investor confidence. The company also maintains a 37-year track record of dividend payments and has reported significant core net new assets for November 2025.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-22 | Morgan Stanley | $148 | $139 | +6% |
| 2025-12-12 | Barclays | $111 | $115 | -3% |
| 2025-12-10 | B of A Securiti | $91 | $88 | +3% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-22 | Morgan Stanley | main | Overweight |
| 2025-12-12 | Barclays | main | Overweight |
| 2025-12-10 | B of A Securiti | main | Underperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 2 ($0.06M) |
| Sells | 14 ($13.94M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 41.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 8.5% (+0.3%)
- Blackrock Inc.: 7.4% (+3.2%)
- JPMORGAN CHASE & CO: 6.8% (+71.6%)
- Dodge & Cox Inc.: 4.7% (-1.6%)
- State Street Corpora: 4.1% (+0.9%)

### Key Risks

1. Heavy insider selling: $14M sold (14 transactions in 90 days).
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_10 improving +1.3% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 0.69 indicates undervaluation relative to growth. Quality metrics strong (margin 36%). Insider selling cluster ($13.9M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $188.3B |
| Beta | 0.94 |
| 52W Range | $65.88 - $104.43 |
| Short Interest | 1.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.69 |
| Forward P/E | 18.4 |
| Current P/E | 21.6 |
| YoY Growth | 17.2% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from 1.4% to 2.6% (+1.3% in 5 days), confirming momentum buildup. Below STRENGTH zone by 0.4pp (needs >3.0% for momentum thesis). MRS_5 at 2.1% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). RSI overbought at 72, risk of mean reversion. OFD pattern: +MTN (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 2.62% (CS: 75) | Neutral |
| RSI_14 | 71.9 | Overbought |
| MACD Histogram | 0.34 | Bullish |
| vs SMA20 | 1.054x | Above |
| vs SMA50 | 1.086x | Above |
| vs SMA200 | 1.141x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $103.74
- **Stop Loss:** $100.14 (3.5% risk)
- **Target:** $107.34 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 383
- **Position Value:** $39,732.42
- **Portfolio %:** 39.73%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite. VIX remains calm at 14.9 (8th percentile) with positive yield curve (+65bps) and healthy breadth (59.2%), though elevated put/call ratio (1.27) suggests institutional hedging despite surface calm. Focus on quality with awareness of hedging activity divergence.*

### Earnings

**Next:** 2026-01-21 (Est: $1.33)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.25 | $1.31 | +5.2% |
| 2025Q2 | $1.10 | $1.14 | +3.8% |
| 2025Q1 | $1.01 | $1.04 | +3.2% |
| 2024Q4 | $0.91 | $1.01 | +10.5% |

---
*RULE-based L3 | 2026-01-07 09:36 | MRS_10*